Insider sale
NOVABRIDGE BIOSCIENCES
$4.47M
6.08M shares
What this filing means
EVEREST MEDICINES LTD plans to sell 6.08M shares of NOVABRIDGE BIOSCIENCES valued at approximately $4.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/10/2023ACC: 0001783937-23-000001
6.08M
Shares to sell
$4.47M
Approx. market value
6.08M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private placement
Termination of a co-development agreement
1/22/2020
6.08MTotal acquired6.08M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/22/2020 | Private placement Termination of a co-development agreement | 6.08M | — |
| Total | 6.08M | ||
Planned & Completed Dispositions1
NASDAQ Stock MarketPlanned
Units to sell
6.08M
Market value
$4.47M
10/24/2023
Total
Units
6.08M
Value
$4.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/24/2023 | 6.08M | $4.47M | NASDAQ Stock Market | Planned |
| Total | 6.08M | $4.47M | ||